GT Biopharma Selected for Oral Presentation at the SITC 2026 Annual Meeting
GT Biopharma was selected for an oral presentation at the SITC 2026 Annual Meeting, running November 4-8 in Phoenix, AZ. The presentation, titled 'Inhibition of the KRAS oncoprotein sensitizes pancreatic cancer to NK cell immunotherapy,' will be given November 6 by Paarth Dodhiawala of the University of Minnesota Medical School in a session on combination therapies involving cell therapy.
Key figures
- Abstract number
- 655
- Presentation date
- 2026-11-06
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.